People wait their turn to receive a dose of vaccine against the coronavirus COVID-19 disease, outside a vaccination centre in the Jordanian capital Amman, on January 13, 2020. Jordan had approved the Sinopharm vaccine for emergency use, after giving the Pfizer-BioNTech jab the green light.
The Hashemite kingdom has officially registered more than 305,000 novel coronavirus cases and nearly 4,000 deaths.
/ AFP / Khalil MAZRAAWI